ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Geriatric Medicine

Top Geriatric Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FRANCISCO RUGAMA MD

Geriatric Medicine

11,595

$1.02M

444
353 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 17%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$88
Average prescription price

Avg: $64

GEORGE CANTU MD

Geriatric Medicine

6,357

$442K

260
215 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $64

ARUNA AGRAHARKAR MD

Geriatric Medicine

4,399

$276K

122
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $64

IVORY GARRETT PRICE MD

Geriatric Medicine

2,581

$206K

244
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

23%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$80
Average prescription price

Avg: $64

FOLASADE OJO MD

Geriatric Medicine

26,715

$1.73M

514
416 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

26%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $64

RADHIKA HARIHARAN MD

Geriatric Medicine

4,287

$183K

307
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 17%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$43
Average prescription price

Avg: $64

YOUCEF SENNOUR MD

Geriatric Medicine

9,078

$650K

563
507 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $64

KATHLEEN ROCKWOOD MD

Geriatric Medicine

4,045

$249K

193
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $64

PEDRO MCDOUGAL M.D. F.A.C.P.

Geriatric Medicine

20,524

$1.57M

1634
1324 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$76
Average prescription price

Avg: $64

ANN GOTSCHALL MD

Geriatric Medicine

8,354

$359K

371
252 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$43
Average prescription price

Avg: $64

JIBRAIL KASPERKHAN M.D.

Geriatric Medicine

44,085

$3.03M

760
682 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

30%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $64

EDID RAMOS-RIVAS M.D.

Geriatric Medicine

3,682

$190K

138
126 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $64

REZIUDDIN SIDDIQUE M. D.

Geriatric Medicine

43,748

$2.66M

1039
860 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

33%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $64

SANTOS SOBERON M.D.

Geriatric Medicine

7,765

$471K

331
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $64

NORBERTO MONTANI MD

Geriatric Medicine

7,179

$432K

276
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $64

GEOFFREY WILLIAMS MD

Geriatric Medicine

2,499

$196K

47
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

30%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $64

VINOD KAUSHIK M.D.

Geriatric Medicine

8,027

$421K

338
331 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

28%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $64

SUNITHA ALEXANDER MD

Geriatric Medicine

3,303

$205K

219
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $64

SUE CROW MD

Geriatric Medicine

14,646

$1.01M

801
697 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $64

GUILFORD ROBINSON M.D.

Geriatric Medicine

8,870

$685K

222
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

16%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$77
Average prescription price

Avg: $64

NEETA NAYAK MD

Geriatric Medicine

29,948

$1.75M

739
611 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

30%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $64

BELINDA VICIOSO MD

Geriatric Medicine

2,517

$152K

247
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $64

ALEJANDRO ARIZMENDI MD

Geriatric Medicine

22,010

$1.61M

1628
1277 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $64

RAVINDRA BHARADWAJ MD

Geriatric Medicine

6,765

$373K

258
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $64

MAMATHA MODEM M.D

Geriatric Medicine

9,292

$460K

502
489 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 17%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $64

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank